Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan

Yurika Ikeda-Dantsuji1, Hideaki Hanaki, Fuminori Sakai

  • 1Research Center for Anti-Infectious Drugs, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.

Insights

Linezolid resistance in methicillin-resistant Staphylococcus aureus (MRSA) emerged in Japan. Mutations in 23S ribosomal RNA genes correlated with resistance levels, suggesting potential nosocomial spread.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Linezolid is an important antibiotic for treating infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
  • Limited use of linezolid for MRSA infections was approved in Japan in 2006.
  • Monitoring the emergence of antibiotic resistance is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate the status and genetic basis of linezolid-resistant MRSA in Japan.
  • To determine the correlation between specific mutations and the level of linezolid resistance.
  • To assess the clonal diversity and potential transmission routes of linezolid-resistant MRSA.

Main Methods:

  • Collection and characterization of 11 linezolid-resistant MRSA clinical isolates from Japanese hospitals (2006-2008).
  • Determination of minimal inhibitory concentrations (MICs) for linezolid.
  • Analysis of mutations in the 23S ribosomal RNA (rRNA) genes using polymerase chain reaction (PCR).
  • Pulsed-field gel electrophoresis (PFGE) for clonal typing.

Main Results:

  • All 11 strains exhibited linezolid resistance with MICs ranging from 8 to 64 μg/ml.
  • A G2576T mutation in the 23S rRNA genes was present in all resistant strains.
  • The level of linezolid resistance correlated with the number of mutated 23S rRNA gene copies.
  • Seven distinct clones were identified among the 11 isolates, indicating potential transmission.
  • Some resistant strains were found in patients with no prior linezolid exposure, suggesting possible nosocomial spread.

Conclusions:

  • The emergence of linezolid-resistant MRSA in Japan is confirmed.
  • The G2576T mutation in 23S rRNA genes is a key mechanism conferring linezolid resistance.
  • The number of mutated rRNA genes influences the degree of resistance.
  • Linezolid-resistant MRSA may spread within healthcare settings, necessitating vigilant surveillance and infection control measures.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antibiotic Selection00:57

Antibiotic Selection

Overview